Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 341 followers
Latest posts
Last updated 2 days ago
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
2 days ago
Following Merck and Moderna’s phase 3 triumph with a Keytruda-paired personalized mRNA...
Beyond the Bandwidth Ceiling: Redesigning Advanced Therapy Operating Models for the Digital Staff Era
2 days ago
Advanced therapy manufacturers are hitting a bandwidth ceiling. Deloitte makes the case...
AusperBio adds $120M series C to advance hep B oligo therapy through phase 3 and beyond
2 days ago
AusperBio Therapeutics has raised $120 million in series C funds to advance...
Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio
2 days ago
BioXcel Therapeutics has filed for bankruptcy and lined up a deal for...
Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
2 days ago
Vivace Therapeutics has named Craig Gibbs, Ph.D., as its new president and...
Genentech doubles down on ADC-resistant cancers with $1B DualityBio pact
2 days ago
Roche’s Genentech is paying DualityBio $45 million upfront for rights to antibody-drug...
China in Global Clinical Development: Why Early Inclusion Matters
3 days ago
Leading biotechs are rethinking China’s role in global clinical development. Early inclusion...
With mRNA back in the spotlight, tRNA shows potential to treat genetic disease
3 days ago
New research coming out of the University of Toronto has shown that...
Research into protein interactions sheds new light on causes of autism
3 days ago
Studying protein-protein interactions might hold the key to identifying druggable targets for...
CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreak
3 days ago
The Coalition for Epidemic Preparedness Innovations has committed up to $16.5 million...
Osivax bags flu vaccine rights to pursue combination shot vision
3 days ago
Osivax has licensed an influenza vaccine from GC Biopharma, positioning the biotech...
After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platform
3 days ago
After announcing the “tough but necessary” decision to lay off some employees...